Weight loss drug tested as potential aid to curb heavy drinking
NCT ID NCT06994338
Summary
This study is testing if a weekly injection called tirzepatide, which is approved for weight loss and diabetes, can also help people reduce heavy alcohol use. It will involve 42 adults who have alcohol use disorder and are overweight or obese. Participants will receive either the real medication or a placebo (inactive shot) for 8 weeks to see if it helps them drink less and improves their health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Keck School of Medicine, University of Southern California
RECRUITINGLos Angeles, California, 90032, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.